Beatriz G de la Torre

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 73

Top Topics

Positive Breast Cancer

Structure Activity Relationship

Silver Nanoparticles

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Chemical communications (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Clinton G L Veale, Abir Chakraborty, Richwell Mhlanga, Fernando Albericio, Beatriz G de la Torre, Adrienne L Edkins, David James Clark
A native mass spectrometry approach to qualitatively elucidate interfacial epitopes of transient protein-protein interactions. Chemical communications (Cambridge, England) 60 (45) (2024)
Rotimi Sheyi, Jessica T Mhlongo, Marta Jorba, Ester Fusté, Anamika Sharma, Miguel Viñas, Fernando Albericio, Paula Espinal, Beatriz G de la Torre
1,3,5-Triazine as Branching Connector for the Construction of Novel Antimicrobial Peptide Dendrimers: Synthesis and Biological Characterization. International journal of molecular sciences 25 (11) (2024)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 29 (3) (2024)
Clinton G L Veale, Abir Chakraborty, Richwell Mhlanga, Fernando Albericio, Beatriz G de la Torre, Adrienne L Edkins, David James Clark
A native mass spectrometry approach to qualitatively elucidate interfacial epitopes of transient protein-protein interactions. Chemical communications (Cambridge, England) (2024)
Rotimi Sheyi, Jessica T Mhlongo, Marta Jorba, Ester Fusté, Anamika Sharma, Miguel Viñas, Fernando Albericio, Paula Espinal, Beatriz G de la Torre
1,3,5-Triazine as Branching Connector for the Construction of Novel Antimicrobial Peptide Dendrimers: Synthesis and Biological Characterization. International journal of molecular sciences 25 (11) (2024)
Danah Al Shaer, Othman Al Musaimi, Fernando Albericio, Beatriz G de la Torre
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Natalia L Cancelarich, Miriam Arrulo, Sariah Trillo Gugliotti, Eder Alves Barbosa, Daniel Carneiro Moreira, Néstor G Basso, Luis Orlando Pérez, Cátia Teixeira, Paula A C Gomes, Beatriz G de la Torre, Fernando Albericio, Peter Eaton, José Roberto de Souza de Almeida Leite, Mariela M Marani
First Bioprospecting Study of Skin Host-Defense Peptides in Odontophrynus americanus . Journal of natural products 87 (7) (2024)
Clinton G L Veale, Abir Chakraborty, Richwell Mhlanga, Fernando Albericio, Beatriz G de la Torre, Adrienne L Edkins, David James Clark
A native mass spectrometry approach to qualitatively elucidate interfacial epitopes of transient protein-protein interactions. Chemical communications (Cambridge, England) 60 (45) (2024)
Sikabwe Noki, Beatriz G de la Torre, Fernando Albericio
Safety-Catch Linkers for Solid-Phase Peptide Synthesis. Molecules (Basel, Switzerland) 29 (7) (2024)
Danah Al Shaer, Othman Al Musaimi, Fernando Albericio, Beatriz G de la Torre
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Natalia L Cancelarich, Miriam Arrulo, Sariah Trillo Gugliotti, Eder Alves Barbosa, Daniel Carneiro Moreira, Néstor G Basso, Luis Orlando Pérez, Cátia Teixeira, Paula A C Gomes, Beatriz G de la Torre, Fernando Albericio, Peter Eaton, José Roberto de Souza de Almeida Leite, Mariela M Marani
First Bioprospecting Study of Skin Host-Defense Peptides in Odontophrynus americanus . Journal of natural products (2024)
Natalia L Cancelarich, Miriam Arrulo, Sariah Trillo Gugliotti, Eder Alves Barbosa, Daniel Carneiro Moreira, Néstor G Basso, Luis Orlando Pérez, Cátia Teixeira, Paula A C Gomes, Beatriz G de la Torre, Fernando Albericio, Peter Eaton, José Roberto de Souza de Almeida Leite, Mariela M Marani
First Bioprospecting Study of Skin Host-Defense Peptides in Odontophrynus americanus . Journal of natural products 87 (7) (2024)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 29 (3) (2024)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 29 (3) (2024)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 29 (3) (2024)
Sikabwe Noki, Beatriz G de la Torre, Fernando Albericio
Safety-Catch Linkers for Solid-Phase Peptide Synthesis. Molecules (Basel, Switzerland) 29 (7) (2024)
Sikabwe Noki, Beatriz G de la Torre, Fernando Albericio
Safety-Catch Linkers for Solid-Phase Peptide Synthesis. Molecules (Basel, Switzerland) 29 (7) (2024)
Clinton G L Veale, Abir Chakraborty, Richwell Mhlanga, Fernando Albericio, Beatriz G de la Torre, Adrienne L Edkins, David James Clark
A native mass spectrometry approach to qualitatively elucidate interfacial epitopes of transient protein-protein interactions. Chemical communications (Cambridge, England) 60 (45) (2024)
Tanya Román, Gerardo Acosta, Beatriz G de la Torre, Constanza Cárdenas, Fanny Gúzman, Fernando Albericio
Improving 2-Chlorotrityl Chloride (2-CTC) Resin Activation. Methods and protocols 6 (5) (2023)
K P Nandhini, Mahama Alhassan, Clinton G L Veale, Fernando Albericio, Beatriz G de la Torre
Methionine-Containing Peptides: Avoiding Secondary Reactions in the Final Global Deprotection. ACS omega 8 (17) (2023)
Othman Al Musaimi, Danah Al Shaer, Fernando Albericio, Beatriz G de la Torre
2022 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Alexander C Martins, Fernando Albericio, Beatriz G de la Torre
FDA Approvals of Biologics in 2022. Biomedicines 11 (5) (2023)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 28 (3) (2023)
K P Nandhini, Sikabwe Noki, Edikarlos Brasil, Fernando Albericio, Beatriz G de la Torre
A safety-catch protecting group strategy compatible with Boc-chemistry for the synthesis of peptide nucleic acids (PNAs). Organic & biomolecular chemistry (2023)
K P Nandhini, Mahama Alhassan, Clinton G L Veale, Fernando Albericio, Beatriz G de la Torre
Methionine-Containing Peptides: Avoiding Secondary Reactions in the Final Global Deprotection. ACS omega 8 (17) (2023)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 28 (3) (2023)
Babita Kushwaha, Sinenhlanhla N Mthembu, Anamika Sharma, Fernando Albericio, Beatriz G de la Torre
Serinol-Based Versatile Disulfide-Reducing Reagent. Molecules (Basel, Switzerland) 28 (14) (2023)
Othman Al Musaimi, Danah Al Shaer, Fernando Albericio, Beatriz G de la Torre
2022 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 28 (3) (2023)
Tanya Román, Gerardo A Acosta, Constanza Cárdenas, Beatriz G de la Torre, Fanny Gúzman, Fernando Albericio
Protocol for Facile Synthesis of Fmoc-N-Me-AA-OH Using 2-CTC Resin as Temporary and Reusable Protecting Group. Methods and protocols 6 (6) (2023)
Othman Al Musaimi, Danah Al Shaer, Fernando Albericio, Beatriz G de la Torre
2022 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 28 (3) (2023)
K P Nandhini, Danah Al Shaer, Fernando Albericio, Beatriz G de la Torre
The challenge of peptide nucleic acid synthesis. Chemical Society reviews (2023)
Damilola Caleb Akintayo, Beatriz G de la Torre, Yongfu Li, Fernando Albericio
Amino-Li-Resin-A Fiber Polyacrylamide Resin for Solid-Phase Peptide Synthesis. Polymers 14 (5) (2022)
K P Nandhini, Fernando Albericio, Beatriz G de la Torre
2-Methoxy-4-methylsulfinylbenzyl Alcohol as a Safety-Catch Linker for the Fmoc/ t Bu Solid-Phase Peptide Synthesis Strategy. The Journal of organic chemistry 87 (15) (2022)
Damilola Caleb Akintayo, Srinivasa Rao Manne, Beatriz G de la Torre, Yongfu Li, Fernando Albericio
A Practical Peptide Synthesis Workflow Using Amino-Li-Resin. Methods and protocols 5 (5) (2022)
Isabel Pérez-Guillén, Oscar Domènech, Adrià Botet-Carreras, Alexandra Merlos, Josep M Sierra, Fernando Albericio, Beatriz G de la Torre, M Teresa Montero, Miguel Viñas, Jordi H Borrell
Studying Lipid Membrane Interactions of a Super-Cationic Peptide in Model Membranes and Living Bacteria. Pharmaceutics 14 (10) (2022)
Srinivasa Rao Manne, Amit Chakraborty, Karin Rustler, Thomas Bruckdorfer, Beatriz G de la Torre, Fernando Albericio
Solid-Phase Synthesis of an "Inaccessible" hGH-Derived Peptide Using a Pseudoproline Monomer and SIT-Protection for Cysteine. ACS omega 7 (32) (2022)
Srinivasa Rao Manne, Anamika Sharma, Andrius Sazonovas, Matti Haukka, Beatriz G de la Torre, Fernando Albericio
Understanding OxymaPure as a Peptide Coupling Additive: A Guide to New Oxyma Derivatives. ACS omega 7 (7) (2022)
Rotimi Sheyi, Beatriz G de la Torre, Fernando Albericio
Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate. Pharmaceutics 14 (2) (2022)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 27 (3) (2022)
Ihab Shawish, Assem Barakat, Ali K Aldalbahi, Walhan Mohammad Alshaer, Fadwa Daoud, Dana A Alqudah, Mazhar Salim Al Zoubi, Ma'mon M Hatmal, Mohamed S Nafie, Matti Haukka, Anamika Sharma, Beatriz G de la Torre, Fernando Albericio, Matti Haukka
Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s -Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades. Pharmaceutics 14 (8) (2022)
Beatriz G de la Torre, Fernando Albericio
Practical Protocols for Solid-Phase Peptide Synthesis 4.0. Methods and protocols 5 (6) (2022)
Ihab Shawish, Assem Barakat, Ali K Aldalbahi, Azizah M Malebari, Mohamed S Nafie, Adnan A Bekhit, Amgad Albohy, Alamgir Khan, Zaheer Ul-Haq, Matti Haukka, Beatriz G de la Torre, Fernando Albericio, Matti Haukka
Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)- s -triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades. ACS omega 7 (28) (2022)
Anamika Sharma, Ashish Kumar, Beatriz G de la Torre, Fernando Albericio
Liquid-Phase Peptide Synthesis (LPPS): A Third Wave for the Preparation of Peptides. Chemical reviews 122 (16) (2022)
Danah Al Shaer, Othman Al Musaimi, Fernando Albericio, Beatriz G de la Torre
2021 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Alexander C Martins, Mariana Y Oshiro, Fernando Albericio, Beatriz G de la Torre, Gustavo José V Pereira, Rodrigo V Gonzaga
Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021. Biomedicines 10 (9) (2022)
María Ángeles Abengózar, María Fernández-Reyes, Vivian A Salazar, Marc Torrent, Beatriz G de la Torre, David Andreu, Ester Boix, Luis Rivas
Essential Role of Enzymatic Activity in the Leishmanicidal Mechanism of the Eosinophil Cationic Protein (RNase 3). ACS infectious diseases 8 (7) (2022)
Azizah M Malebari, Rakia Abd Alhameed, Zainab M Almarhoon, Muhammad Farooq Khan, Mohammad A M Wadaan, Anamika Sharma, Beatriz G de la Torre, Fernando Albericio, Matti Haukka
The Antiproliferative and Apoptotic Effect of a Novel Synthesized S-Triazine Dipeptide Series, and Toxicity Screening in Zebrafish Embryos. Molecules (Basel, Switzerland) 26 (4) (2021)
Nikita Devnarain, Ayman Y Waddad, Beatriz G de la Torre, Fernando Albericio, Thirumala Govender
Novel Biomimetic Human TLR2-Derived Peptides for Potential Targeting of Lipoteichoic Acid: An In Silico Assessment. Biomedicines 9 (8) (2021)
Anamika Sharma, Rotimi Sheyi, Beatriz G de la Torre, Matti Haukka, Fernando Albericio
s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation. Molecules (Basel, Switzerland) 26 (4) (2021)
Amit Chakraborty, Fernando Albericio, Beatriz G de la Torre
Chemoselective Disulfide Formation by Thiol-Disulfide Interchange in SIT-Protected Cysteinyl Peptides. The Journal of organic chemistry 87 (1) (2021)
Clinton G L Veale, Maria Mateos-Jiménez, Michaelone C Vaaltyn, Ronel Müller, Matodzi P Makhubu, Mahama Alhassan, Beatriz G de la Torre, Fernando Albericio, C L Logan Mackay, Adrienne Lesley Edkins, David James Clark
A native mass spectrometry platform identifies HOP inhibitors that modulate the HSP90-HOP protein-protein interaction. Chemical communications (Cambridge, England) 57 (83) (2021)
Srinivasa Rao Manne, Omar Luna, Gerardo A Acosta, Miriam Royo, Matti Haukka, Gyorgy Orosz, Beatriz G de la Torre, Fernando Albericio
Amide Formation: Choosing the Safer Carbodiimide in Combination with OxymaPure to Avoid HCN Release. Organic letters 23 (17) (2021)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 26 (3) (2021)
Othman Al Musaimi, Danah Al Shaer, Fernando Albericio, Beatriz G de la Torre
2020 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Estelle J Ramchuran, Isabel Pérez-Guillén, Linda A Bester, Rene B Khan, Fernando Albericio, Miguel Viñas, Beatriz G de la Torre
Super-Cationic Peptide Dendrimers-Synthesis and Evaluation as Antimicrobial Agents. Antibiotics (Basel, Switzerland) 10 (6) (2021)
Beatriz G de la Torre, Fernando Albericio
Peptide Therapeutics 2.0. Molecules (Basel, Switzerland) 25 (10) (2020)
Amit Chakraborty, Anamika Sharma, Fernando Albericio, Beatriz G de la Torre
Disulfide-Based Protecting Groups for the Cysteine Side Chain. Organic letters 22 (24) (2020)
Mahama Alhassan, Ashish Kumar, John Lopez, Fernando Albericio, Beatriz G de la Torre
Revisiting NO2 as Protecting Group of Arginine in Solid-Phase Peptide Synthesis. International journal of molecular sciences 21 (12) (2020)
Sinenhlanhla N Mthembu, Anamika Sharma, Fernando Albericio, Beatriz G de la Torre
Breaking a Couple: Disulfide Reducing Agents. Chembiochem : a European journal of chemical biology 21 (14) (2020)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 25 (3) (2020)
Rakia Abd Alhameed, Zainab M Almarhoon, Essam Nageh Sholkamy, Salman Ali Khan, Zaheer Ul Haq, Anamika Sharma, Beatriz G de la Torre, Fernando Albericio, Matti Haukka
Novel 4,6-Disubstituted s-Triazin-2-yl Amino Acid Derivatives as Promising Antifungal Agents. Journal of fungi (Basel, Switzerland) 6 (4) (2020)
Jessica T Mhlongo, Edikarlos Brasil, Beatriz G de la Torre, Fernando Albericio
Naturally Occurring Oxazole-Containing Peptides. Marine drugs 18 (4) (2020)
Ashish Kumar, Mahama Alhassan, John Lopez, Fernando Albericio, Beatriz G de la Torre
N-Butylpyrrolidinone for Solid-Phase Peptide Synthesis is Environmentally Friendlier and Synthetically Better than DMF. ChemSusChem 13 (19) (2020)
Othman Al Musaimi, Alessandra Basso, Beatriz G de la Torre, Fernando Albericio
Calculating Resin Functionalization in Solid-Phase Peptide Synthesis Using a Standardized Method based on Fmoc Determination. ACS combinatorial science 21 (11) (2019)
Beatriz G de la Torre, Fernando Albericio
The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules (Basel, Switzerland) 24 (4) (2019)
Ashish Kumar, Anamika Sharma, Beatriz G de la Torre, Fernando Albericio
Scope and Limitations of γ-Valerolactone (GVL) as a Green Solvent to be Used with Base for Fmoc Removal in Solid Phase Peptide Synthesis. Molecules (Basel, Switzerland) 24 (21) (2019)
Danah Al Shaer, Othman Al Musaimi, Fernando Albericio, Beatriz G de la Torre
2018 FDA Tides Harvest. Pharmaceuticals (Basel, Switzerland) 12 (2) (2019)
Anamika Sharma, Rotimi Sheyi, Ashish Kumar, Matti Haukka, Beatriz G de la Torre, Fernando Albericio
Investigating Triorthogonal Chemoselectivity. Effect of Azide Substitution on the Triazine Core. Organic letters 21 (19) (2019)
Rakia Abd Alhameed, Zainab M Almarhoon, Sarah I Bukhari, Matti Haukka, Beatriz G de la Torre, Fernando Albericio
Synthesis and Antimicrobial Activity of a New Series of Thiazolidine-2,4-diones Carboxamide and Amino Acid Derivatives. Molecules (Basel, Switzerland) 25 (1) (2019)
Sinenhlanhla N Mthembu, Anamika Sharma, Fernando Albericio, Beatriz G de la Torre
2-(Dibenzylamino)butane-1,4-dithiol (DABDT), a Friendly Disulfide-Reducing Reagent Compatible with a Broad Range of Solvents. Organic letters 21 (24) (2019)
Othman Al Musaimi, Danah Al Shaer, Beatriz G de la Torre, Fernando Albericio
2017 FDA Peptide Harvest. Pharmaceuticals (Basel, Switzerland) 11 (2) (2018)